N

Nureca

(NSE: NURECA)

NURECA

868.95

0.00 (0.00%)

Nureca Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Nureca Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Nureca Price Summary

Today High

894.95

Today Low

862.25

52 Week High

894.95

52 Week Low

862.25

Nureca Fundamentals

Market Cap

1280.4 Cr

CASA

0.0

No. Of Shares

1.0 Cr

P/E

12.9

P/B

3.7

Face Value

10.0

Dividend Yeild

0.3

Book Value

163.3

Net Interest Income

17.6

Cost to Income

NA

Promoter Holdings

70.0

EPS

46.5

CAR

NA

ROE

52.5

ROCE

66.8

Profit Growth

NA

Nureca Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Stampede Capital

15.1

NA

NA

NA

NA

NA

NA

NA

Nureca

868.95

1280.4 Cr

3.7

12.9

46.5

52.5

66.8

17.6

Dolat Algotech

71.6

1258.4 Cr

3.4

8.4

8.3

50.3

59.6

NA

Vinyl Chemicals

674.45

1221.3 Cr

3.1

18.7

6.2

17.6

23.5

1.20 L

Ugro Capital

190.9

1211.2 Cr

0.9

29.6

4.1

3.1

3.9

NA

PNB Gilts

61.45

1136.8 Cr

0.7

1.9

25.2

38.5

8.3

NA

FAQ’s on Nureca

About Nureca

Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in. 

The company has most of the product lines supporting home health market in India, making it a one-stop solution provider. Dr Trust is a known for its innovative products in the market, and, with the segment showing significant potential for growth, the company is positioned to show significant growth.

The company has a diversified product portfolio, which primarily caters to home healthcare sector. It provides an improved product mix to its customers and their preferences thereby targeting a wider customer base. Its growth is further driven by its ability to make available an assortment of quality products under trusted brands built by the company.

Products:

Currently, the company classify its products portfolio under the following five categories such as:

  • Chronic Device Products - which includes products such as blood pressure monitors, pulse oximeters, thermometers, nebulizers, self monitoring glucose devices, humidifier and steamers.
  • Orthopedic Products - which includes rehabilitation products such as wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers.
    Mother and Child Products - which includes products such as breast pumps, bottle sterilizers, bottle warmers, car seats and baby carry cots.
  • Nutrition Supplements - which includes products such as fish oil, multivitamins, probiotics, botin, apple cider and vinegar.
  • Lifestyle Products - which includes products such as smart scales, aroma diffusers and fitness tracker.

Key awards, recognitions and accreditations

  • 2020: The company received ISO 9001:2015 Certificate of Registration from Intertek Certification Limited for Management System, which is applicable to sales, services and warehousing of medical devices, consumer electronics, pharmaceutical and personal care products.
  • 2020: Appreciation Letter from Pharmaceuticals Export Promoter Council of India stating the company as a very dynamic and evolving medical devices company and has created a credible and leading brand ‘Dr. Trust’ which is now a household name in India.

Major events and milestones:

  • 2016: Online launch of Dr. Trust Brand.
  • 2017: Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.
  • 2017: Started three flex centres in Punjab, Karnataka and Uttar Pradesh.
  • 2018: The company became the wholly owned subsidiary of Nectar Biopharma Private Limited.
  • 2018: Added three flex centres in Chandigarh, Telangana and Maharashtra.
  • 2018: Secured warehouse drug license.
  • 2020 Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the company pursuant to the Scheme of Arrangement.

Trade Nureca today

Create a free portfolio in Trinkerr and earn and grow along with peers